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Background: Vaccination against influenza is considered the most important public health intervention to prevent
unnecessary hospitalizations and premature deaths related to influenza in the elderly, though there are significant
inequities among global influenza vaccine resources, capacities, and policies. The objective of this study was to
assess the social determinants of health preventing adults ≥ 65 years old from accessing and accepting seasonal
influenza vaccination.
Methods: A systematic search was performed in January 2011 using MEDLINE, ISI – Web of Science, PsycINFO, and
CINAHL (1980–2011). Reference lists of articles were also examined. Selection criteria included qualitative and
quantitative studies written in English that examined social determinants of and barriers against seasonal influenza
vaccination among adults ≥ 65 years. Two authors performed the quality assessment and data extraction. Thematic
analysis was the main approach for joint synthesis, using identification and juxtaposition of themes associated with
vaccination.
Results: Overall, 58 studies were analyzed. Structural social determinants such as age, gender, marital status,
education, ethnicity, socio-economic status, social and cultural values, as well as intermediary determinants
including housing-place of residence, behavioral beliefs, social influences, previous vaccine experiences, perceived
susceptibility, sources of information, and perceived health status influenced seasonal influenza vaccination.
Healthcare system related factors including accessibility, affordability, knowledge and attitudes about vaccination,
and physicians’ advice were also important determinants of vaccination.
Conclusions: Our results demonstrate that the ability of adults ≥65 years to receive seasonal influenza vaccine is
influenced by structural, intermediate, and healthcare-related social determinants which have an impact at the
health system, provider, and individual levels.
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The global burden of inter-pandemic influenza is estimated
at 1 billion cases of flu, 3–5 million cases of severe illness,
and 300,000-500,000 deaths annually [1], with about
90% of all influenza-related deaths occurring in adults
aged 65 years or more and well-defined risk groups
[2,3]. Influenza is an important contributor to the
annual increase in hospitalizations and deaths attributed
to pneumonia and influenza that is observed during the
winter months, particularly among those ≥65 years old
or those with chronic medical conditions including
pulmonary, cardiovascular, or renal diseases as well as
immunosuppression [3]. The primary goal of influenza
vaccination in these high risk groups is to prevent unneces-
sary hospitalizations and premature deaths related to influ-
enza, since episodes of influenza tend to exacerbate chronic
medical conditions and lead to the occurrence of secondary
bacterial pneumonias.
In the general population, immunization against
influenza is considered the most important public health
intervention to control seasonal, epidemic, and pandemic
influenza [3-5]. Priority approaches and strategies to
respond to an influenza pandemic are to achieve appropri-
ate rates of vaccine uptake [6]. This would increase seasonal
vaccine demand to stimulate market forces and augment
supply, thus expanding the production capacity in a sus-
tainable way [4,5]. There are, however, marked differences
among countries’ capacities, priorities, and resources to
establish influenza vaccination policies and strategies [7-10].
There have been previous reports, reviews [11], and
a recent Cochrane systematic review [12] to assess the
effectiveness of vaccines in preventing influenza,
influenza-like illness, hospital admissions, and mortality in
the elderly. For community dwelling elderly, the adjusted
analyses from cohort and case control studies in the
Cochrane review show that the effectiveness of the vaccine
is modest, with reductions in the risk of hospitalizations
for influenza or pneumonia, for respiratory or cardiac
diseases, and for all-cause mortality (cohort studies)
or death specifically from influenza and pneumonia
(case–control studies) [12].
Other studies have tried to identify determinants of
seasonal influenza vaccination [13], but few have focused
on identifying social determinants within a framework
of health equity [14] or their focus has been in other
age groups [15]. Social determinants of health (SDH)
play a critical role in disease occurrence, distribution,
and consequences.
A Cochrane review about interventions to increase
influenza vaccination rates of the elderly in the community
found (with evidence from randomized controlled trials
in developed countries) that personalized postcards and
phone calls are effective, home visits and facilitators
may be effective, but reminders to physicians are not[16]. This review did not include randomized controlled
trials of society-level interventions or qualitative studies.
To improve the understanding of the multidimensional
challenge of yearly seasonal influenza vaccination
among the elderly, the aim of this review was to assess
the barriers that prevent elderly people from accessing
and accepting seasonal influenza vaccine and its related
social determinants. We used the conceptual framework
that the Commission on Social Determinants of Health
(CSDH) developed to identify determinants linked to sea-
sonal influenza vaccination. This framework is based on a
social production of disease approach, in which individual
health outcomes and diseases and their unequal distribu-
tion across population groups are the result of the inter-
action of several determinants operating at different
domains [17,18] (Figure 1). This framework contains three
types of determinants: 1) Structural determinants; 2) Inter-
mediate determinants; and 3) Determinants associated
with the healthcare system.
Methods
In this systematic review we considered qualitative and
quantitative studies on seasonal influenza vaccination
and related interventions among elderly adults (age ≥ 65)
living in the community or in nursing homes in high,
middle, and low income countries (Table 1). The outcome
measure of interest was vaccine coverage and the exposures
of interest were barriers that patients and health services
faced to obtain and deliver seasonal influenza vaccine
as well as the social health determinants linked to
those barriers. Since the aim of our study was not the
effectiveness of the vaccine, but the barriers (and their
related social determinants) that may affect vaccine
uptake, we searched qualitative and descriptive studies
that answered questions about structural determinants
(e.g. individual socio-economic conditions, public policies,
cultural norms) as well as intermediate determinants of
health (e.g. attitudes, beliefs, lifestyles) [17,18].
Search strategy
Following the study protocol, we searched MEDLINE,
ISI – Web of Science, PsycINFO, and CINAHL databases.
The search strategy considered studies published in the
English language between 1980 and 2011, using qualitative
research terms or filter terms (Appendix 1). After the first
search and before any qualitative screening or data extrac-
tion were done, initial research questions were detailed and
refined and the search strategy and search terms were
modified accordingly. One reviewer (JN) screened all titles
and abstracts identified from literature search for relevance
based on inclusion criteria (n = 1261) (Table 1). Citations
that did not meet the inclusion criteria, were irrelevant
for the aim of the study, or had unclear methods were
excluded (n = 1123), as were duplicates (n = 23) (Figure 2).
Figure 1 Commission on Social Determinants of Health conceptual framework (Solar & Irwin, 2010 [17]).
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considered relevant were obtained (JN) and assessed for
inclusion (n = 115) (CF, IH). The reference lists of relevant
articles and reviews were back searched for additional
studies (n = 43). During full-text review, citations were
excluded using the same criteria as above (n = 68). Two
authors (CF, IH) assessed the quality and extracted the data
of those studies meeting all the inclusion criteria (n = 90).
Review methods: quality assessment
Two reviewers independently assessed the quality of
selected studies by utilizing the Quality Assessment and
Review Instrument (QARI) checklist [19]. Data were
extracted and compared using adapted forms of the
Cochrane Effective Practice and Organization of Care
Group (EPOC) which includes separate strategies for
qualitative and quantitative data. Each study was read
independently by two reviewers (CF, IH). Disagreements
between reviewers were resolved by a reconciliation
process to achieve consensus. A priori, we decided to
appraise the quality of qualitative studies as part of our
exploration and interpretation of the paper, but not
exclude them based on a rigid checklist, since new
insights, grounded in data, might be generated even in
studies classified as with low methodological quality. In
addition, different structured appraisal approaches may
not have consistency in their judgments about the
inclusion of studies [20,21].Synthesis approach
Our objective in summarizing data from quantitative
and qualitative studies was to explore the types and
sources of barriers to seasonal influenza vaccination
among elderly people and their related social determi-
nants. Since qualitative synthesis was our main interest,
we used meta-ethnography [22] and meta-synthesis [23]
frameworks, which have been used increasingly in
healthcare research [24-26]. For qualitative data synthesis,
we created a list of themes and subthemes, compared and
juxtaposed them, and determined their relationships using
grids and tables [22]. Given the heterogeneity of study
designs, we also listed recurrent themes and factors associ-
ated with vaccine uptake or refusal in quantitative studies.
Thematic analysis was our main approach to joint synthesis
and was used to identify major categories, based on primary
data rather than prior knowledge [24,26]. Finally, we
compared the themes to the Commission for Social
Determinants of Health conceptual framework to make
them most applicable for policy makers [18].
Results
Overall, 80 studies were identified as suitable for this
review. Given the limited number of studies retrieved
about nursing homes (5), homebound patients (2), and
interventions (15, from 3 countries) we decided to leave
those topics for future studies. From the 58 studies
included, 13 used qualitative methods, 3 used mixed
Figure 2 Flowchart of the systematic search.
Table 1 Inclusion and exclusion criteria
Definition of inclusion criteria Exclusion criteria
Population of interest Adults ≥65 years old, irrespective of setting Adults < 65 years old
Children
Studies that only include specific subpopulations
irrelevant for study aim (i.e. diabetes, HIV)
Intervention of interest Seasonal influenza vaccination Interventions not related to seasonal influenza,
(AH1N1, pandemic or epidemic periods,
vaccine shortage)Actions to address barriers against vaccination (i.e. advertising,
provider mailings, patient and staff education, visiting nurses)
Comparisons of interest Not been immunized Different vaccines
Populations without access to immunization
Outcome measures of periods before seasonal immunization campaigns
Populations or groups without the intervention that promote
immunization or avoid barriers
Exposures of interest Barriers against vaccination
Social determinants of health
• Socio-economic & political context: governance, policy
(macroeconomic, social, health), cultural and societal norms and values
• Social position: education, occupation, income, gender, ethnicity/race
• Material circumstances, social cohesion, psychosocial factors,
beliefs, behaviours, biological factors
• Health care system, distribution of health and well-being
Outcome of interest Vaccine coverage Pharmacological aspects of the vaccine
Study designs Qualitative (case-studies, ethnography, grounded theory,
phenomenology; or specific techniques as focus groups, in-depth
interviews, surveys, participant observation)
Reviews, cost-effectiveness or economic analyses
Quantitative (descriptive, cross sectional, case–control, cohort,
randomized controlled trial), mixed-methods
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quantitative or descriptive methods (Appendix 2). There
were 13 studies about policy and strategy problems, six
about healthcare providers, and 39 regarding patients’
beliefs, attitudes, socio-economic factors, or material
circumstances. Nine studies were multinational, including
countries from Asia, Europe, Latin America, and the
Middle-East. More than half of the studies were done in de-
veloped countries. Only six studies included patients from
rural areas [27-35]. Qualitative data collection techniques
included one-on-one interviewing, questionnaires, key
informant selection, focus groups, participant observation,
participatory action research, and community mobilization
techniques. Quantitative studies encompassed mainly
descriptive studies and cross sectional surveys, two ecologic
studies, and one controlled trial [36].
Themes about SDH emerged from each component
of the immunization process (policy and governance,
healthcare systems, provider, and patient) and were
organized according to the categories in the conceptual
framework of the SDH (Figure 1): structural, intermediate,
and health system determinants (Table 2). In addition,
barriers and determinants of patient’s beliefs and behaviors
on influenza vaccination are described in Figure 3, while
reasons for vaccine acceptance or refusal among elderly
adults are summarized in Table 3.
Structural determinants
Beyond individual factors influencing exposure and vulner-
ability, the conceptual framework on SDH emphasizes the
role of structural determinants, which are the social
and political mechanisms that generate and maintain
social hierarchy and stratification such as labor markets,
education systems, social protection regimes, political
institutions, and cultural and societal values. These factors
influence the level of power and resources that a society
can redistribute among its different population groups.
These structural mechanisms shape social hierarchies
according to income, education, occupation, social class,
gender and race/ethnicity. They are the root cause of
inequalities in health.
Policy and governance level
An initial consideration is that most reports included in
this review focused in high-income countries. Low and
middle-income countries (as well as rural and peri-urban
populations) were underrepresented, demonstrating the
larger structural determinants that influence availability,
access, and information about benefits of seasonal influenza
vaccination in the elderly. The main themes identified in
this review about policies and programs regarding seasonal
influenza immunization and socially explained immuno-
logic inequities were: insufficient seasonal influenza vaccine
(SIV) availability for all countries, need of fully fundedimmunization programs and public health promotion,
and lack of consensus on immunization practices and
harmonization of target groups (Table 2).
Insufficient seasonal influenza vaccine available for all
countries to reduce immunization inequities
While there has been an increase in the availability of
SIV since 2006 by increased production, there are still
gaps in the availability of influenza vaccine production
capacity for low and middle-income countries in the
event of a pandemic [5,37,38]. The continuous need to
update antigen selection on a yearly basis according to
the circulation of viral strains is a major health system
barrier leading to inequities in the availability of the vaccine
in non-producing countries, particularly low and middle
income countries. While there has been an expansion in
the number of countries using seasonal influenza vaccine,
today, no country has fully implemented its own vaccine
recommendations. Substantial variations in influenza
vaccination coverage persists among countries in most
regions of the world [9,37,39-41].
Provider and healthcare system
Programmatic barriers: lack of consensus on immunization
practices, strategies, and target groups
As important as the availability of a yearly SIV is the
design and implementation of programmatic strategies
and activities to achieve adequate levels of effective
immunization coverage among high-risk populations
(including adults ≥65 years). Even in industrialized
countries, significant population groups at risk of com-
plications from influenza are not vaccinated or refuse
the vaccine. Countries that provide reimbursements
for healthcare practitioners to administer SIV or that
provide the vaccine within public health insurance
coverage tend to have higher seasonal influenza vaccination
rates for the elderly [7,10,39,41-45].
Currently, there is little agreement on ideal vaccination
strategies and on the selection of target groups to receive
SIV. There is also lack of consensus of the benefit of
seasonal influenza vaccination in the elderly [40]. In some
regions, the lack of harmonization of vaccination strategies
and of selection of high-risk populations has contributed to
insufficient vaccination coverage of some target groups
[9,42]. Some studies have shown that nationwide vac-
cination programs maybe a better strategy to decrease
influenza-associated mortality in the elderly [45,46].
Patients
Determinants of health related to personal characteristics
have been studied to understand which factors may
increase the likelihood of vaccine uptake or to identify the
population groups to which intervention efforts must be
focused on. However, the findings have not always been
Table 2 Themes that emerged at structural, intermediate, and health care systems levels




Vaccine supply Insufficient seasonal influenza vaccine available
for all countries to reduce immunization inequities.
MIV [41], Partridge [38], Kieny [5]
Finances Fully funded immunization programs. Reimbursement. Strong recommendations may be insufficient
because patients might accept the vaccine
but cannot afford it.
Kunze [43], Lataillade [10], Fedson [39]
Public health promotion Awareness of the population through public health
information. Promotion about influenza, policy
recommendations, and high risk groups for
vaccination.
“There was little knowledge about target
groups for vaccination in Poland, Turkey
and South Africa- countries without
immunization programs” (Lataillade).
Lataillade [10], Kwong [44]
“Awareness of influenza in countries without
influenza immunization programs was poor.
In South Africa and Turkey in 2005–06
influenza was not distinguished in severity




Programmatic barriers: lack of
consensus on immunization
practices, strategies, and target
groups
Recommendations, strategies and practices to
vaccinate elderly adults, in outpatient clinics or in
nursing homes, are not standardized and vary from
country to country. Lack of harmonization of target
groups and strategies.
Michel [42], Lataillade [10], Fedson
[39], MIV [41], Ropero-Alvarez [37],
Kroneman [7], Nakatani [45]
1.3 Patient-related Gender Some reports suggest that men are more likely to be
vaccinated, and that likelihood of vaccination may
change with age for both genders, but both without
confirmation in multivariate analyses. No difference
by gender was reported in other studies.
Nowalk [47], Shemesh [48], Evans
[49], Mangtani [33], Abramson [50],
Sarría Santamera [28], Gauthey
[51], Chiatti [53], Lopez de Andres
[32], O‘Malley [27], Armstrong [52]
Gender and occupational roles Occupational roles and responsibilities for childcare
may decrease the likelihood of being vaccinated.
“Responsibilities for childcare may also
influence access to care” (Adonis).
Adonis [2], Daniels [67], Peña –Rey [32]
“Non–care givers (of children, old people,
or sick people) had an increased probability
of being vaccinated” (Peña-Rey).
Age Age has been associated with vaccination uptake in
some cross-sectional surveys. Overlap of other
factors such as chronic diseases or limitations of
functional status must be considered. Others report
no difference by age.
Peña-Rey [32], Lopez de Andres [32],
O‘Malley [27], Shemesh [48], Evans
[49], Chiatti [53], Armstrong [52]
Marital status Being married or living with others has been
associated with vaccination acceptance in some
studies. However, other reports found no
relationship. Overlap with issues about social support,
access difficulties, or regular preventive health care
must be considered.
Mangtagni [34], Damiani [14],
O‘Malley [27], Nowalk [47], Gauathey
[51], Sarria- Santamera [28],
Zimmerman [30] Abramson [50]
Education Higher education level has been associated in some
reports with higher vaccination rates. However,
scales to measure educational attainment and results
Abramson [50], O‘Malley [27], Chiatti
[53], Damianni [14], Sarría Santamera




















Table 2 Themes that emerged at structural, intermediate, and health care systems levels (Continued)
are not consistent. Others report no influence of
education in vaccine uptake or a reverse gradient.
Health-related print literacy may have an influence.
Race – ethnicity Higher vaccination rates in whites than in African
Americans and Hispanics have been found in the US.
Other reports found no differences by ethnic group.
In other countries, minority groups may have lower
vaccination rates. Language and education may also
be related.
O‘Malley [27], Lindley [31], Zimmerman
[29,30], Shemesh [48] Nowalk [57],
Bardenheier [58]
Some ethnic groups have
specific fears and mistrust of
modern medicine, provider, or
the health care system
Specific racial groups, like African-American elderly
in the US, commented mistrust of the healthcare
system and fears.
“We have a general distrust of the medical
profession, and we have beliefs in home
remedies and that kind of thing.” “Black,
people, we have fears. We have fears of the
healthcare community - you know, the
Tuskegee stuff” (Daniels).
Daniels [67] Harris [63]
Language and literacy barriers
for physician contact or for
written campaign information
Minority elders prefer to speak to their provider or
read written materials in their native language.
“… I like to go to the Haitian doctor
because I can speak with him and do not
get embarrassed”. Participants preferred to
be interviewed in Creole (Adonis-Rizzo).
Adonis-Rizzo [2], Lasser [71], Daniels
[67], O‘Malley [27]
Socio-economic level This multi-dimensional concept was measured with
different variables across studies. Lower
socio-economic status has been correlated with
lower vaccination uptake; however, other reports
showed no difference, or even reverse gradient.
Peña- Rey [32], O’Malley [27], Nowalk
[47], Chiatti [53], Mangtani [34],
Sarría-Santamera [28], López de
Andres [32].
Presence of chronic diseases Vaccination rates have been higher among patients
with chronic diseases, adjusting for gender, age, and
other factors. Other reports have found the
association only in bivariate analysis.
Chiatti [53], Evans [49], Damiani [14],
López de Andres [32], O‘Malley [27],
Abramson [50]
Cultural values and health
beliefs: healthy living for
prevention of illness
Health beliefs include the desire to improve health,
the importance of healthy living, and behaviors and
lifestyles important for prevention of illness and
health promotion. Refusers may have reliance on
healthy lifestyle and avoidance of close contacts.
Community perceptions to not get vaccinated are a
barrier to immunization.
“My father had a saying, which he repeated
again and again: it is better to pay the
butcher and the baker than the doctor …
I still continue today in the way my father
and mother brought us up, meat, fish,
vegetables …” (acceptor) “keep away from
people, you know, because I think myself,
what gives you flu if you don’t have the
needle, I think you get flu by being with a
lot of people you see” (acceptor who
became refuser) (Telford)
Sengupta [65], Telford [66], Cornford
[62], Adonis-Rizzo [2], Evans [64], Daniels
[67], Kwong [69], Zimmerman [30]
“Well, it’s for my health so I’m going to do it,
if it’s the best thing for me” “If they (churchgoers)
felt that the flu shot were to their advantage,
they would stand in line for five or 10 minutes
and get the shot and then go home” (Daniels).
Sense of community - protect
others
Sense of responsibility to protect self and others in
the community. Word-of-mouth from the
community to get the flu shot.
“I think so, yes I think so a lot (friends say
that to you as well, a general feeling that
vaccination is a good thing to do), that’s




















Table 2 Themes that emerged at structural, intermediate, and health care systems levels (Continued)
the first think on their minds. You all see
that you all get it. It reminds you and you
remind others. Make sure we all get it”
(Vaccinated from UK).
Local beliefs, perceptions, and
knowledge: indigenous health
practices to avoid or treat
influenza
Local understandings of the cause of influenza as a
natural illness (as opposed to other that come from
outside- competing paradigms), that can be treated
with natural remedies, food and warm clothing, as
well as the awareness of the potential severity of
the disease.
“I thought that it is just a big cold … Can
you explain it to me? … I don’t know what
is it, I though I was just a cold” [they
consider flu a natural illness, traditional
preventive practices would seem sufficient,
and the potential for complications was
not considered] (Adonis-Rizzo).
Kwong [8,69], Cameron [70], Sengupta
[64] Adonis-Rizzo [2], Daniels [67]
Trust or lack of it in the health
care system, provider, or
modern medicine
Lack of trust in the vaccine. Fears and mistrust in the
healthcare system.
“Well I would say, if you get recommendations
from the Government and the medical
profession and they both urge you to do these
things, well do’em …” (acceptor) “The first time,
I had it on the Tuesday morning and by night I
was out with my sisters and friends, .. I went
shivering, shaking, so I left them, and got a taxi
home and took a couple of powders and went
to bed. The next morning I was as right as rain,
and I’ve had it twice since then and it’s never
affected me”. “We have a general distrust of the
medical profession, and we have beliefs in
home remedies and that kind of thing.”
(Daniels). “I don’t like doctors and hospitals
all that much” (Evans)





Housing – place of residence Data about differences between rural and urban
settings are contradictory and depend on country
and health system characteristics. Place of residence
may determine ease of access to vaccination, and
socio-economic status may affect living conditions
(central heating or not, rented or owned house).
Mangtani [33,34], Lopez de Andres [32],





Type of practice VA system has higher vaccination rates compared to
non-VA practices due to its use of multimodal
interventions to increase rates such as freestanding
vaccination clinics, patient reminders, standing
orders, and regular assessment of vaccination rates
with incentives to clinicians.
Zimmerman [30]
Influenza vaccination in the
previous year
One of the most important predictors of vaccine
uptake. However, does not always reflect current
attitudes towards vaccination.
Lasser [71], Harris [63], Telford [66],
Kwong [8], Evans [49], Zimmerman [30],
Armstrong [52] Cornford [62], Nowalk [47]
2.3. Patient-related Behavioural beliefs about
consequences of vaccine uptake
Different frameworks proposed. Behavioral beliefs
are based on the patient’s probability calculation
of susceptibility to and severity of influenza, their
knowledge about vaccine effectiveness, and their
healthcare and social cost of the vaccine.
Bosompra [35], Zimmerman [29],




















Table 2 Themes that emerged at structural, intermediate, and health care systems levels (Continued)
Social influences. Advice from
family or peers may trigger
vaccine acceptance
Cautious willingness. Patients trust their family
members, as well as peers or known community
members’ advice.
“My daughter told me about it, I had it done
based on her recommendation. I had it done
because I trust my daughter. I didn’t hesitate
(Vaccinated, South Korea, Kwong). “I have to
ask my children before that. If they say I should,
I’ll receive this injection. If they say no, I will not
receive it …” “I will talk with my friends, people
of the same age and with the same health
condition could help us decide whether to get
the flu shot or not. If they decide against it, I do
not want to do it either” (Payaprom).
Evans [64], Adonis-Rizzo [2], Lasser [71],
Payaprom [46], Schensul [36], Daniels
[67], Kwong [8,61], Zimmerman [29,30],
O‘Malley [27], Lau [73]
Prior experiences of influenza
or with influenza vaccine (IV)
Own or observed prior experiences, positive or
negative, of influenza or with IV in previous years.
“My brother in law got it and he was in the
hospital for more than a month with the flu,
with fever, vomits, he got everything.” “Ay
cuñada don’t do it”, so I never got it. No, no,
I won’t do it” (Lesser).
Lasser [71], Harris [63], Telford [66],
Kwong [8,44], Bardenheier [58] ,
Bosompra [35], Evans [64]
Concerns about the vaccine
safety, effectiveness, side
effects. Fear of pain, injections,
and getting the disease with
the vaccine
Negative experiences or anecdotes and fear of mild
or severe side effects and pain. Refusers are more
likely to believe IV had serious side effects, that it is
ineffective, and be skeptical or have no confidence
in the vaccine.
“… it was purely that I didn’t like needles
and people, you’d hear about these
side-effects; al the side affects you have from
that flu jab, oh you can’t lift your arm and
you’re sick” (refuser who became acceptor)
(Telford) “I’ve heard so many people being
bad (ill) after it …” (Evans)
Lasser [71], Telford [66], Evans [64],
Daniels [67] Kwong [44,61], Armstrong
[52], Bardenheier [58], Harris [63],
Cameron [70], Sengupta [65],
Adonis –Rizzo [2], Shemesh [48],
Zimmerman [29,30], Kwong [44]
“My sister has the flu every year, and she
takes the shot! … I said well that doesn’t
make sense. And she has it real bad. So I
never bothered with it”. “I thought if I took
the flu shot I might get a cold, get the flu”.
“I take it, the flu shot, then, I get the flu”




If positive experiences occurred after the first
shot, every year the patient will continue with IV.
“I took it and I will take it from now on”
(Schensul).
Harris [63], Schensul [36], Lau [73],
Zimmerman [30]
“The habit of being vaccinated” (Zimmerman).
Perceived risk or susceptibility Perceived susceptibility based on patient’s awareness
and previous knowledge of the disease.
“I think the good part outweighs the risky
part of it. Just like with normal shots, the
same thing. You may get pneumonia you
may get sick, but probably 96% of people,
this is going to save them in some way”, “I
take it so I won’t be as sick. It does make me
feel bad, but I still get up and go. You know?”
Evans [49], Kwong [8,44], Telford [66],
Bosompra [35]
Perceived severity of influenza,
previous awareness and
knowledge about influenza
Fear of disease. Knowledge and beliefs about severity
of influenza and its contagiousness. Some patients
think influenza is serious for others, but not themselves.
Contrasting opinions. “It is not the worst
thing in the world. It can be dealt with” vs.
“You really, really, really feel really sick”, “you
feel like you going to die” (Cameron). Being
knowledgeable about the severity of the flu:
“I have had the flu, and I know how sick you
can get from it” (Payaprom).
Cornford [62], Cameron [70], Payaprom




















Table 2 Themes that emerged at structural, intermediate, and health care systems levels (Continued)
Lack of knowledge.
Misconceptions about influenza
or IV. Curative vs. preventive effect.
Misconceptions about adult
vaccination
Misconceptions about influenza and about the
vaccine might be prevalent in some communities,
and should be approached with correct information
sources.
“I normally get the tetanus booster every 10 years
as it comes up. And I can see the benefits of the
pneumonia, the pneumovac … For older people.
As far as the flu, I’ve never had the flu, so I don’t
get the vaccine” (Daniels). “The vaccine is good,
really, so that it will take out all the infection that
you have, like that, really”, “then they put the
vaccine (flu), the flu comes, and you throw out a
lot of phlegm” (Daniels).
Payaprom [46], Daniels [67],
Armstrong [52]
Perceived or self-appraised health
status. Awareness of IV indications
Self-perception of “poor” health has been associated
with vaccine acceptance, whereas self- perception
of “good” health may be a reason for non-uptake.
Perceived risk (low or high, age related) of
contracting influenza, the knowledge of personal
risk factors and awareness of vaccine indications are
important factors. Some elders believe that influenza
carries no risk for healthy older people. Some
patients are not able to relate the potential risk of
mortality from influenza to themselves or to others
unless a pre-existing condition or other health issue
is present.
“Young people can fight it”, “I think because
you’re older, resistance is low” (Cameron). “Well, I
really don’t be sick … I ’m in a pretty good
shape the doctors say”. “I am a person that don’t
catch colds very easily” (Cameron) “Yes, I believe
it could be (that death could occur) but not
directly because of the flu, because when the flu
is developed where there is high temperature
and low defenses, that could trigger another kind
of disease that is present but unseen. … he
could have lived for a long time, but he caught a
very bad flu, and it forced him to stay in bed.
That happens to elderly people when they stay
in bed for a long time, especially on their backs,
and it gets complicated. It complicates with the
lung, and he died, but truly, you can’t say that it
was only because of the flu” (Daniels).
Cornford [62] Evans [49], Cameron [70],
Sengupta [65], Payaprom [46] Daniels
[67], Kwong [69], Zimmerman [30],
Damiani [14], Peña-Rey [32], López de
Andres [32], Mangtani [33].
Perceived cost of the vaccine.
Free, low, or high cost.
Reimbursements
If financial barriers exist, even patients who have
accepted the vaccine will not receive it.
Misunderstandings or misinformation about cost of
influenza vaccine exist.
“Right now, I don’t have a good income and
so even if I wanted to couldn’t get the flu
shot” (Kwong) “I got mine because it was
free”, “some of the problem [is] they don’t
have health insurance and cannot afford to
pay for these things” “Also cost, better health
insurance for, insurance making it (flu vaccine)
available that way” (Sengupta).
Kwong [8,61], Cameron [70],
Sengupta [65], Lasser [71], Lau [73]
Perception of health care cost
and social cost
Cost of treatment of disease or its complications. “The flu shot is not expensive if it is effective $80
is cheap … I need to pay several hundreds to
treat influenza-related diseases. The cost of the flu
shot is lower” (vaccinated from China, Kwong).
Kwong [8], Lau [73], Cameron [70],
Sengupta [65], Lasser [71]
An increase of the chances to infect their family
members, particularly for elderly adults living with
other persons including family and grandchildren.
My doctor advised my daughter to have me
get the flu shot, so I do so every year. My
daughter as two lovely children … and they
usually get sick during winter … We live






Different aspects of accessibility for the elderly
are distance to the health center, convenience of its
location, transportation, language, access to




















Table 2 Themes that emerged at structural, intermediate, and health care systems levels (Continued)
Convenience. Vaccine delivery
may be enhanced in more
convenient places for elderly
people
Elderly people may consider having the vaccination
if it is provided locally, near their home, or in
convenient community delivery places as
pharmacies, shopping malls, and supermarkets.
“The health center is fine. It’s near our houses and
it’s not crowded. If it’s the hospital, you have to
spend one day because the hospital service is
very slow and my children have to take me
there” (Payaprom). “In terms of flu shots, it’s, I
think, a whole matter of convenience” “The only
reason my husband had a flu shot was that he
happened to be in supermarket, and they were
doing them” (Daniels).
Payaprom [46], Cameron [70],
Daniels [67], Adonis –Rizzo [2],
Faith based organizations or
other community organizations
as venues for adult
immunization delivery
Churches were perceived as convenient and
accessible community locations, trusted organizations
in the community, and sites where a significant
number of older adults regularly convened. Peer
models, bulletin posters, and support from faith-
based leaders may be used to give encouragement.
“I think the church is a good place for
vaccinations because a lot of people go there”,
“I think it would be a good place. Obviously,
there needs to be other places too, for people
that don’t go to church. But I think you would
find a lot of them - I know that the older
generation does tend to go to church or go
back to the church at some point” (Daniels).
Daniels [67]
Depend on others for
transportation
Most patients did not drive and are dependent on
their children, friends, or church members for
transportation. This dependence makes return
visits more difficult to schedule.
“It is hard to drive … If my children can take
me where the vaccine is being offered, I will
definitely take it” (Adonis)
Adonis-Rizzo [2], Daniels [67],
Zimmerman [29], Lasser [71]
Language and literacy barriers
for physician contact or written
campaign information
Cultural competencies of provider are desirable and
needed to deliver preventive messages and to
convince patients to get vaccinated.
“… I like to go to the Haitian doctor because
I can speak with him and do not get
embarrassed”. Participants preferred to
be interviewed in Creole (Adonis).
Adonis-Rizzo [2], Lasser [71], Daniels
[67], O‘Malley [27], Kwong [61]
Immigration status Having to sign forms with names and addresses
may elicit fears related to legal immigration status.
Some adults fear losing access to services.
“Yes, yes, I have heard commentaries that they
don’t get near the vaccines because “I am
illegal”. Now, yes and they are distrustful, really,
because you have to sign papers with your
name” “The hospital that I go, they tell you
every year to go and get the vaccine. Then, I go
and get the vaccine because I am scared that
they would take away my assistance” (Daniels).
Daniels [67]
Affordability and cost Elderly people may consider having influenza
vaccination if it is provided free of charge. Some
patients felt that knowledge of the costs and
benefits of the IV may be a motivating factor to
increase immunization.
“They should (get vaccination). But what
would they do? Elderly people without any
income support can only live day by day”
(Payaprom) “ If the black community were
more aware of these free vaccines - I mean,
it’s going to be cost-effective for them
health wise, and also for HMOs because you
don’t need to fill up a hospital with a bunch
of people with pneumonia” (Daniels).
Payaprom [46], Cameron [70], Daniels
[67], Lau [73], Kwong [8,61], Sengupta
[65], Lasser [71],
Health insurance or preventive
services. Lack of knowledge
about insurance coverage and
IV cost
Some patients had limited knowledge and
understanding of the existing healthcare insurance
coverage for the flu vaccine. Lack of health insurance,
insurance status, and cost were important considerations.
“The lack of care would make people to seldom
receive the vaccines or prevent them from
receiving them. It is that they don’t have a
doctor, people don’t have access to doctors “.
Adonis-Rizzo [2], Lasser [71], Daniels
[67], Zimmerman [29,30], O‘Malley [27]
Recent visits to the health
care center
The use of medical care or services and the frequency
of contacts with the health care system may increase
Abramson [50], O’Malley [27], Peña-Rey




















Table 2 Themes that emerged at structural, intermediate, and health care systems levels (Continued)
the opportunities for receiving counseling and




Advice from physician or
professional health care provider
Physicians’ recommendations are one of the most
frequently reported influences on immunization
status. Patients trust their provider’s advice. However,
providers cover many topics in visits and may not
talk about IV or recommend it. Providers must be
proactive, have consistency in their
recommendations, and promote vaccination with
patient reminders.
“My doctor never told me about it .... If he
recommended I would take it” (Adonis). “I
don’t remember being reminded to get a flu
shot. I used to go to a general practitioner
and perhaps he could mention that … My
gynecologist doesn’t talk about flu shots. I
have an oncologist, he doesn’t talk about flu
shots - so most of my doctors are more
linked to specific conditions, they’re specialist,
and they don’t talk about flu shots”. “But, I
don’t remember on any regular basis- any
doctor or nurse- saying to me … for
instance; I just got notice in the mail that it
was time to have my mammogram. And
then I thought - okay. I will do that. But I’ve
never gotten anything in the mail or from my
doctors saying “It is time to have your flu shot”.
Adonis-Rizzo [2], Armstrong [52],
Bardenheier [58], Evans [49,64], Lasser
[71], Daniels [67], Kwong [8,61], Gauthey
[51], Zimmerman [29,30], Lau [73],
Payaprom [46], Schensul [36], Shemesh
[48], O’Malley [27], Nowalk [47] ,





Healthcare provider acceptance of seasonal influenza
vaccine depends on demographic factors such as
years of practice, being up-to-date with scientific
journals, and cultural factors. Other factors that
promote vaccine acceptance are communication
strategies include information giving skills, cultural
competency, empathy, persistence, trust, and
vaccination by the provider. Availability and
distribution of the vaccine in a timely basis are
determinants of the perceptions of the practitioners.
Other environmental factors include logistical and
competing demands.
Zimmerman [31], Pavia [76], Lasser
[71], Pyrzanowski [75], O’Malley [27]
3.2. Patient related Sources of information Suggestions on how to effectively provide information
on the significance of influenza immunization to the
health of older adults. Suggested strategies included
those through the healthcare system, media,
community-based organizations, and churches.
Advertisements through television, radio, newspaper
and magazines may not be as effective as desired.
“I think if you had multiple sources of
information - if you had it through the
church, the announcements at church or the
bulletin, on TV, on the radio, in the
newspapers … then you could remember
where and when (to get the flu shots)”. (Daniels)
Daniels [67], Zimmerman [29]
Source of information about influenza
vaccine recommendations are medical
professionals, television, newspapers,




















Figure 3 Factors affecting seasonal influenza vaccination in the elderly.
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http://www.biomedcentral.com/1471-2458/13/388consistent, and some of the reasons that could explain the
variability are: 1) associations found in cross-sectional
surveys are not causal associations and confounding might
affect them; 2) some demographic variables (such as
education, socio-economic status, or household income)
are defined in different ways or proxy measures are used,
thus limiting the comparability among studies and
countries; 3) real differences may exist among groups,
regions, or countries due to characteristics of the popula-
tion, the influenza program, or the healthcare system.
Gender
Some studies have found that men are more likely to
be vaccinated in comparison with women [34,47-49].
However, such differences were present only in bivariate
analysis and disappeared in multivariate regression analysis
(i.e. 85% of men vaccinated vs. 75% of women [33];
76.1% of men vs. 60.3% of women, OR 2.1 p < 0.0001)
[50]. Sarría-Santamera reports that with increasing age,
the likelihood of vaccination among women decreased,
but the likelihood among men increased [28]. Gauthey
found that although vaccine coverage was higher amongmen (39.9 vs. 32.7%, p = 0.04), differences between genders
became smaller and statistically insignificant with in-
creased age [51]. Other reports have found no difference
by gender [27,52-54].
Age
Age has been associated with vaccination uptake in
different cross-sectional surveys. Chiatti found that
influenza vaccination was more likely among adults ≥85
years (73.5%, adjusted odds ratio (AOR) 1.8, 95% CI 1.6-2.0,
p < 0.01), or those 75–84 years old (70.5%, AOR 1.7,
95% CI1.6-1.8, p < 0.01), than in those aged 65–74 [53].
Similarly, Lopez de Andres found a greater vaccination
likelihood in patients ≥75 years (OR 2.4, 95% CI 2.0-2.8),
and 70–74 years (OR 1.6, 95% CI 1.3-2.0), than in those
aged 65–69 years [54]. The effect of age on vaccination
may appear among patients with or without associated
chronic diseases [53,54]. However, limited functional status
may decrease the likelihood of vaccine uptake since access
might depend on transportation or assistance, unless living
in a nursing home. One study found no relationship
between age and influenza vaccination status [52].
Table 3 Reasons for vaccine acceptance or refusal among elderly adults
Reasons for acceptance Reasons for refusal
Personal facilitators Personal barriers
Positive attitude to prevention. Desire to avoid flu Not knowledgeable about flu or severity of flu
Recommended by physician or nurse, by mail, or personally Low educational attainment, low health-related printed literacy
Recommended by friend or relative Misconceptions about immunization in adults
Being knowledgeable about the severity of the flu Perception of low susceptibility to the disease due to good health
status: “Not likely to contract influenza”
Having “not very good health” Lack of knowledge about indications of influenza vaccine in
general or for himself
Having a chronic condition that puts them at higher risk for getting the flu Unjustified medical reasons (allergy to drugs, chronic illness)
Having had a job that puts them at a higher risk for getting the flu Lack of interest, forgot to get it, never considered it before
Positive prior experiences with the vaccine or only mild side effects Anecdotes or prior negative experiences with the vaccine
Benefits of the flu shot Concerns or fears about risks of the flu shot
Prevention Side effects, pain, fear of injections
Decreases symptom severity of the flu Fear of undisclosed shot contents
Greater ability to do day-to-day activities Misconception of getting influenza from the vaccine
“Do not pass influenza to my family and friends” Disbelief in vaccine efficacy
Perceived consequences: thought that unvaccinated persons
would probably contract influenza
Previous bad reactions and past problems with flu shot batches
Free vaccine: Social Security pays for it Accessibility problems: transport, distance, convenience, unable to
attend because ill health, language
Getting older Cost: patient unable to afford the shot. Lack of knowledge
about insurance coverage
Structural facilitators Structural barriers
Physician’s recommendation/reminder to get the shot Word of mouth from the community to not get a flu shot
Visits to the physician Irregular or lack of preventive healthcare
Word-of-mouth from the community to get a flu shot Doctor did not recommended the vaccine, missed opportunities
Written or visual media promoting flu shot use Lack of access
Vaccine is free or low cost Regarding vaccine shortage
Type of physician Regarding location access
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Being married and having social support has been
associated with vaccination acceptance. Abramson
reports higher vaccination rates in married patients
compared to unmarried patients (74% vs. 56%, AOR 2.1,
95% CI 1.3-3.5, p = 0.003), though weaker associations
have been also reported (AOR 1.45, 95% CI 1.05-2.01 [32];
AOR 1.3, 95% CI 1.2-1.4), [27]. In Italy, widowed and single
persons were less likely to be vaccinated compared to
married persons (OR 0.83, 95% CI 0.77-0.88) [14]. People
who live alone with limited assistance may have less access,
irregular preventive health visits, and less support from
family members. However, other reports have found no
relationship of marital status with vaccine uptake [28,51].
One study reported higher immunization rates among
single or never married patients (93%, AOR 9.2, 95% CI
2.9-29, p = 0.001), compared to married (84%, AOR 2.6,
95% CI 1.3-5.4, p = 0.01), widowed (80%, AOR 2.0, 95% CI
1.0-3.9, p = 0.05), or separated/divorced (69%) persons [30].Education
Higher education levels have been associated with higher
vaccination rates; however, different scales have been used
to measure education attainment, limiting the comparabil-
ity among the studies. Abramson found the association
strongest in bivariate analysis (55% with ≤8 years, vs. 72%
with ≥9 years of school, p = 0.0007) [50], though a slight
positive gradient with increased educational level was also
reported (AOR for ≥ college degree 1.3, 95% CI 1.2-1.5)
using multivariate regression [27]. Conversely, a reverse
gradient was reported in Italy, with greater vaccination
rates in the group without a primary school degree (66.5%)
than in the group with a high school degree or more
(59.3%), although this difference was not significant in
multivariate analysis [53]. Other studies have found no
influence of education on vaccination [14,28]. Individuals
with higher educational attainment may have more access
to regular preventive healthcare, resources to overcome
barriers, awareness about healthy lifestyles, and confidence
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Conversely, elderly persons with lower educational
attainment may have lower socio-economic status,
may be more likely to have strong cultural beliefs, and
may rely more heavily on indigenous health practices.
Furthermore, health-related print literacy (the ability to
use health information from printed sources to make
appropriate health decisions) significantly mediates racial
and education-related disparities in self-rated health status
and use of influenza vaccination [56]. Therefore, different
levels of educational attainment are related to health
literacy and influenza vaccination use.
Race-ethnicity
Ethnicity has been recognized as one of the markers of
health inequity and most studies on race come from the
US where social and health inequalities among ethnic
groups have been well-documented [57]. For example, in
a cross-sectional survey of Medicare beneficiaries in the
US, white patients had significantly higher odds of influenza
vaccination compared to black patients (AOR 1.5, 95% CI
1.4-1.7) adjusting for patient, physician, health system,
and area level characteristics [27]. A wide difference in
the proportion of African Americans (50.2%), Hispanics
(31.7%), and whites (20.7%) that had not received an
influenza vaccination has also been reported [58]. In
a survey of inner-city neighborhood health centers,
Zimmerman reported lower vaccination rates for blacks
(60%) in comparison with white patients (79%) [29]. In
other countries there are few reports about vaccination
rates in ethnic minority groups. In a survey conducted
in a health fair in Israel, there was higher influenza vaccine
coverage among Arabic (80.8%) and Hebrew (68.7%)
speakers, as compared with Russian (33.5%) speakers,
immigrants from the former Soviet Union [48]. Conversely,
other reports have found no significant differences by race
[30], particularly after controlling for socio-demographic
characteristics [59]. Health literacy significantly mediates
racial/ethnic disparities in vaccination uptake [56].
Socio-economic status (SES)
SES is a multi-dimensional concept that may vary with
context. SES was measured as income, occupation, highest
individual class within the household, or deprivation index
for the district in which patients resided. Lower SES has
been found to be correlated with lower vaccination uptake
[32,34,47]. Patients with higher income were found to have
significantly higher probabilities of vaccine uptake in Spain
(AOR 1.4, 95%CI 1.01-1.9) and in the US (AOR 1.3,
95%CI 1.1-1.5) [27,32]. Interestingly, a reverse gradient has
been found in some countries where health policies and
influenza programs have been effectively implemented. In
Italy, influenza vaccination was more prevalent in lower so-
cial classes (65.1%, AOR 1.2, 95% CI 1.1, 1.3, p < 0.01), thanin upper social classes (56.9%) [53]. In Brazil, in an ecologic
study comparing age-specific (≥65 years) mortality rates be-
fore and after the onset of yearly vaccination, deprived areas
of the city (with poorer profiles of human development,
lower health indices, and lower incomes) had more signifi-
cant decreases in mortality by pneumonia and influenza
during the vaccination period [60]. Other surveys found no
association of SES with vaccination status [28,54].
Presence of chronic diseases (CD)
Because CD are an indication for influenza vaccine
administration, the frequency of vaccination is expected
to be higher with the presence of CD [61]. For example, in
Italy vaccination was significantly higher among patients
with severe CD such as severe diabetes, cardiac disease, or
chronic pulmonary obstructive disease (70.7%, OR 2.0,
1.8-2.1, p < 0.01); and mild CD (60.1%, OR 1.4, 1.3-1.6,
p < 0.01); than in their absence (47%) adjusting for gender,
age, social class, education, self-reported health, and having
a general practitioner visit in last month [53]. In the UK,
the likelihood of vaccination increased as the number of
CD increased, adjusted by gender, age, health status, and
hospital visits (for 1 CD, AOR 2.5, 95% CI 1.9-3.2; for 2
CD, AOR 3.2 95%CI 2.0-5.1; and for ≥3 CD, AOR 4.0. 95%
CI 1.2-12.9) [49]. Having at least one CD was associated
with a higher vaccination rate in Italy (AOR 1.53, 95%CI
1.45-1.62) [14], in Spain (AOR 1.6, 95%CI 1.3-1.9) [54],
and in the US with two or more CD vs. none or one (AOR
1.6, 95% CI 1.4-1.7) [27]. In Israel, 75.2% of patients
with CD were vaccinated in comparison to 64.7% with-
out CD (p = 0.0067), but the difference was statistically
significant only in the bivariate analysis [50].
Cultural values and health beliefs about vaccination
Vaccinated persons are more confident in the effectiveness
of the vaccine and value its benefits to their families and
communities. For some elderly people, health represented
the absence of medical diseases and the ability to be
independent and actively engage with other people [62].
Protecting and helping others, ideals of “healthy living,”
and trust in providers may be part of cultural norms
[30,36,49,62-69]. The contribution of vaccination to family
and community health may be stressed in countries with a
strong cultural heritage that values the protection of the
family. In these communities, patients may give more
weight to the social benefit of vaccination than to the finan-
cial cost [8]. Conversely, unvaccinated patients are more
likely to trust indigenous health practices, rely on healthy
lifestyles, and doubt the effectiveness of vaccines. Local un-
derstandings of the causes of influenza place it as a natural
illness, which can be treated with broths and warm clothing
[8,65,68-70]. Therefore, effective interventions to promote
influenza vaccination must understand cultural beliefs and
practices and use them to complement immunization [8].
Nagata et al. BMC Public Health 2011, 13:388 Page 16 of 25
http://www.biomedcentral.com/1471-2458/13/388Intermediate determinants
We grouped in this category factors that operated at
the individual level including lifestyles, personal be-
liefs, perceptions, behaviors, individual choices material
conditions, or psychosocial factors. By adopting a social
causation of disease approach, we find that the unequal
distribution of these factors becomes the primary
mechanism through which socio-economic position
generates health inequities [18].
Policy and governance level
Housing – place of residence
As a person’s place of residence may determine ease of
access to vaccination, some studies have included an
index of deprivation of the area of residence, or categorized
areas as urban or rural [34]. Simultaneously, SES influences
living and health conditions and perceptions related to
them. For instance, patients living without central heating
or living in rented accommodation were 10% less likely to
be vaccinated compared to patients with central heating or
home-owners. Practices located in areas with high
indices of deprivation or with relatively high mortality rates
reported lower vaccine uptake in adults >74 years [33,34].
In Spain, living in a town with more than 10,000 inhab-
itants increased the likelihood of patient’s vaccination
(AOR 1.4, 95% CI 1.2-1.6) [54]. In contrast, one report
showed that urban settings had a lower likelihood of
influenza vaccination than rural towns (AOR 0.7, 95%
CI 0.6-0.8), while another study demonstrated that
people 65–69 years old living in cities with more than
one million inhabitants had lower vaccination rates
than those living in cities with less than one million
inhabitants [27,28].
Provider and healthcare system
Type of practice
Zimmerman reports (without statistical significance) higher
vaccination rates in patients from Veterans Affairs (VA)
practices (91%) compared with non-VA practices in
inner-city (67%), suburban (79%), or rural (79%) locations
[30]. Higher vaccination rates in the VA system may be due
to its use of multimodal interventions to increase rates
such as freestanding vaccination clinics, patient reminders,
standing orders, and regular assessment of vaccination rates
with incentives to clinicians [30].
Influenza vaccination in the previous year
Quantitative studies have also found that vaccination in
the prior year is one of the most important predictors of
vaccine uptake in the elderly. For instance, Zimmerman
reports that in a sample of 1,007 telephone interviews,
99% of respondents who stated they were vaccinated
planned on being vaccinated in the following year,
compared to only 25% of respondents who stated theywere not currently vaccinated (p < 0.001) [30]. Nowalk
presents similar findings in a study in which 98% of
respondents vaccinated in the 2000–2001 influenza
season reported their intention to obtain an influenza
vaccination in the following year, compared to 39% of
those who were unvaccinated (p = 0.0001) [47]. Therefore,
intention is one of the strongest predictors of behavior. If
patients have a positive initial vaccination experience, they
are likely to seek the vaccination year after year and get
“in the habit” of being vaccinated [30,36]. However, one
qualitative study found that vaccination status of previous
year did not always reflect current attitudes towards
vaccination, as a few vaccinated patients decided they
would not be vaccinated the following year [62].
Patient
Behavioral beliefs about consequences of vaccine uptake
Behaviors related to immunization have been analyzed
in different frameworks [8,29,35,47,69]. One such model
posits that patients’ vaccination preferences are determined
by behavioral beliefs based on their probability calculation
of susceptibility to influenza and their utility calculation
of vaccine, healthcare, and social costs [8]. Behavioral
beliefs are dependent on their normative beliefs that are
also moderated by structural determinants such as cul-
tural values and health beliefs (Figure 3).
Prior experiences of influenza or vaccination
A patient’s own or observed prior experiences of influenza
or influenza immunization are strong forces guiding
behavior preference and normative beliefs [30,35,52,64,71].
The prevalence of beliefs in favor of vaccination was
dependent on how predominantly the belief became
normative in the country.
Concerns about the vaccine
Patients in different countries refuse the vaccine because
they think the vaccine itself can cause illness, is ineffective,
has moderate/severe side effects, produces pain, or contains
undisclosed ingredients. Conversely, vaccinated people had
confidence in the vaccine effectiveness and recognized the
vaccine as a preventive measure which may decrease the
severity of the symptoms and likelihood of contagion to
family and households (Table 3).
Perceived risk or susceptibility
This concept refers to the self-estimated risk that
patients calculate depending on their awareness about
the severity of influenza, the indications of the vaccine,
the probability of contagion, and their susceptibility.
Older age or having a chronic condition which increases
their risk for influenza may make patients realize their
susceptibility. Being knowledgeable about the severity
of the flu and the benefits of the vaccine are facilitators
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shaped by confidence in vaccine effectiveness, fear of
side effects, and fear of getting the flu with the vaccine
[29,30,48,52,61,64,66-69,71].
Societal and cultural differences should be considered
in terms of perceived risk and susceptibility. In China, some
elderly people believed in the benefits of vaccination, had
no cost barriers, and did not fear side effects. However, if
they did not perceive themselves as susceptible, they were
not afraid of getting influenza and did not believe its com-
plications to be serious [69]. In another study specifically
among never immunized people aged 65 and over, predic-
tors of acceptance of SIV were the perceived likelihood of
getting influenza (AOR 2.1, 95% CI 1.1-4.0, p = 0.03), the
recognition that side effects of IV were less risky than the
disease itself (AOR 4.9, 95% CI 2.3-10.8, p < 0.001), and the
recognition that everyone over 65 years should receive the
vaccine (AOR 76.5, 95% CI 16.1-363.8, p < 0.001) [49].
Perceived or self-appraised health status
Patients who perceive themselves with poor health status
are expected to have higher vaccination rates if they believe
they have a higher susceptibility of contracting influenza or
suffering its consequences (Table 2). Assessing self-health
status as “poor” or “no good” was associated with higher
vaccine use in Spain (AOR 1.2, 95% CI 1.1-1.5) [32,54] and
in Italy (AOR 1.5, 95% CI 1.4-1.6) [14]. Similarly, patients
with perceived “good” health were significantly less likely to
be vaccinated (50.3%, AOR 0.73, 95% CI 0.68-0.76, p < 0.01)
in comparison with patients with “fair” health status
(64.5%, as the referent), or with “bad” health status
(71.1%) [53]. In another study, patients refusing SIV who
reported good health (44%) were likely to have better SES
(owner occupied housing with central heating), live in
non-urban areas, and have no previous experiences with
influenza [33]. Other reports showed no association of
health status with vaccination uptake [28,50].
Calculated cost of vaccination
Patients calculate the expected cost or utility when
assessing their own risk and experiences with influenza
vaccination. The calculation is compounded by: 1) the
cost of the vaccine itself (critical barrier); 2) the healthcare
costs for the treatment of influenza, or its complications if
the patient remains unvaccinated and get the disease; and
3) the social cost, which is the perceived risk of infecting
family members or caregivers [8,65,70,71,73,74].
Health systems
The health system is a social determinant of health and
its role becomes particularly relevant through the issue
of access, which determines who will be able to get a
healthcare intervention. Health systems can address
differences in exposure and vulnerability by improvingequitable access to care and promoting policies that
tackle bottlenecks such as geographic barriers to access
healthcare. Although we consider the overall the health
system as an intermediary determinant, given its important
role, we grouped all factors related to it in this section.
Policy and governance level
Accessibility of seasonal influenza vaccine
Accessibility is an important concern for elderly adults
and has multiple aspects: distance and convenience of
health center locations, hours of immunization services,
transportation, language and literacy, health insurance,
and legal status. Vaccine delivery may be enhanced in
convenient locations for elderly people, such as pharmacies,
supermarkets, and churches (Table 2). Elderly people may
be dependent on others for transportation [68] and ease of
access through different means of transportation has been
reported [29]. Language is another access barrier as elders
from minority groups prefer to speak to their provider in
their native language [68]. Some measures to provide infor-
mation and increase the likelihood of vaccine acceptance
are the production of diffusion materials in the patient’s
native language and conducting information meetings in
their language or with a facilitator [36]. Literacy barriers
must be also considered, since specific populations may
have low literacy levels or no schooling and may ignore
written information [61]. Thus, to avoid language and cul-
tural barriers, cultural competency is one of the strategies
to improve communication with patients and to convince
them to accept immunization [71].
Affordability of seasonal influenza vaccine
Cost is an important determinant in countries where
patients have to pay for the vaccine [69]. Elderly people
may consider having the influenza vaccination if it is
provided free of charge. Some patients reported limited
knowledge and understanding of the existing healthcare or
insurance coverage for the flu vaccine [29,30,67,70,72,73],
particularly among those that had irregular or no access to
preventive healthcare [27,65,67,68,71].
Recent visits to the healthcare center
A positive association between the frequency of visits to a
physician and influenza immunization might be expected
since patients can receive advice or the immunization itself.
For instance, in Israel 72% of subjects who had visited their
physician in the last three months were vaccinated, in
comparison to 55% among those without recent visits
(AOR 2.6, 95% CI 1.5-4.8, p = 0.0006) [50]. In the US, four
or more outpatient visits during the year previous to the
survey increased the likelihood of influenza vaccination
(AOR 1.6, 95% CI 1.5-1.8) [27]. Similarly, Spanish women
with at least one physician visit in the last two years
had significantly higher probabilities of being vaccinated
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that when the time of last visit was greater than six
months, the likelihood of not being vaccinated increased
with age (65–69 years: AOR 1.9, 1.1-3.3; ≥70 years: AOR
2.3, 95% CI 1.5-3.6) [28]. However, there was a significant
association between outpatient or inpatient hospital visits
during the previous year and reported influenza vaccine
uptake in multivariate analyses [49].
Provider and healthcare
Health professionals’ influences
Several studies have found that physician advice is
significantly associated with vaccination uptake [30,47,48,
51,71,73,74]. Patients trust their physicians and also
follow advice from trusted family members and peers
[8,29,36,61,64,68,72]. There are reports that many physi-
cians do not offer the vaccine to their patients. Potential
explanations may be that doctors cover many topics during
the visits, give low priority to vaccination in adults, forget
to propose it, underestimate the key influence vaccines can
play, disbelieve vaccine effectiveness, believe that patients
will refuse it, or believe the vaccine is not convenient and
easily accessible during the visit [8,36,49,58,72]. Other stud-
ies have suggested that some patients make appointments
specifically to get vaccinated [8]. In addition, receiving a
reminder from a doctor to get the flu shot is an important
structural facilitator for immunization [65].
Availability and physicians’ awareness, knowledge,
attitudes, and practice
An important determinant of influenza vaccination is
the perception of community-based health practitioners
about adequacy of vaccine stocks such as the availability
and distribution of the vaccine on a timely basis and
interruptions in its supply during some seasons [31,75].
Physicians’ awareness and agreement with official recom-
mendations for vaccination were consistently associated
with higher immunization status. In particular, proactive
office systems (with standing orders tracking, chart
checklist, vaccine clinics), education, and physicians may
influence patients’ intentions to receive seasonal influenza
vaccine [31]. In Italy, a survey among general practitioners
found that a positive attitude towards hospitalizations
being reduced by SIV was significantly more common
in physicians with fewer years of professional activity
(p = 0.05), who work more hours per week (p = 0.013),
and who relied on scientific journals as a source of
information (p = 0.002) [76]. Moreover, a qualitative study
about encounters between primary care physicians and
elderly patients found that communication strategies and
information giving skills, such as sharing of power and
responsibility, empathy, and treating the patient like
a person, facilitated communication and promoted
acceptance of flu vaccination. Other facilitators includedcultural competence, provider introduction of the discus-
sion, persistence throughout the visit, trust and rapport
among patient and physician, and provider vaccination of
the patient [27,71].
Patient
Sources of information about vaccine
As noted earlier, the recommendation of influenza vaccin-
ation by the physician, family, and peers can motivate
vaccine uptake [27,29,30,51,52,61,73,74]. Vaccinated
patients, compared to unvaccinated patients, were more
likely to report that their doctor (99% vs. 80%, p < 0.001)
and family/friends (90% vs. 59%, p = 0.007) thought they
should get the SIV [47]. Important sources of information
for elderly people are newspapers, television, magazines,
radio, and media in general [27,30]. However, few surveys
asked if the information given through national influenza
campaigns were seen or were considered useful to promote
vaccination. For instance, being exposed to advertisements
arguing the need for SIV via television, radio, magazines, or
newspapers was not significantly associated with vaccine
uptake [49,61].
Discussion
The effectiveness of influenza immunization for both
seasonal and pandemic influenza depends upon a timely
and sufficient supply of the vaccine. Even if all social
barriers to implement or strengthen seasonal influenza
immunization in the elderly are removed, equitable
access to SIV remains an issue for many low- or middle-
income countries. There is an increasing push by the
World Health Organization to eliminate disparities in
seasonal immunization rates among and within Member
States as part of resolution World Health Assembly
(WHA) 56.19, which in 2003 recommended the adoption
and/or strengthening of influenza vaccination policies to
increase seasonal influenza vaccination coverage among
populations at high risk of complications and death [5].
The WHO Global Influenza Vaccine Action Plan has
improved the availability of seasonal influenza vaccine for a
significant number of middle and low-income countries
[37,38]. As a result, influenza vaccination is increasing
throughout the world, especially in middle-income
countries of Latin America and Central and Eastern
Europe. Of note, countries that provide reimbursement
for healthcare practitioners to administer influenza
vaccine or provide seasonal influenza vaccine within
their public health insurance coverage tend to have higher
seasonal influenza vaccination for the elderly [39,41].
However, no country has fully implemented its own
vaccine recommendations and substantial variations in
influenza vaccination persist among countries in most
regions of the world [37,39,40]. Even in wealthy indus-
trialized countries, significant population groups at risk
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refuse the vaccine. In this systematic review, we iden-
tified the importance of social determinants of health
in regards to seasonal influenza immunization. This
is relevant given the current efforts to expand sea-
sonal influenza vaccination into low and middle in-
come countries. Decision makers, when designing
public health interventions, can consider the full
range of determinants that influence the effective
coverage of programs. As many of these determinants
operate outside the health sector, decision makers will
also need to consider the adoption of mechanisms for
intersectoral action.
Socio-cultural aspects and social support may affect
vaccine acceptance. At an individual level, factors
such as physicians’ advice, cost, convenience, perceived
susceptibility, prior experiences, health status, personal
beliefs, and misconceptions about the vaccine and the
disease mainly shaped the vaccine acceptance among
this population [30,47,48,51].
In contrast to other routine immunizations, the effective-
ness of seasonal influenza vaccine requires yearly adminis-
tration to high-risk groups that develop complications or
death associated with influenza infection. Due to the
constant risk of antigenic drift, there is a need for yearly
selection of circulating viral strains, and the effective-
ness is directly related to the degree of match between
vaccine virus and circulating strains. This feature adds
other important financial and programmatic barriers to
the expansion of seasonal immunization agendas that
has burdened some national immunization programs in
prioritizing financial and human resources.
Once the historical, financial, political, and epidemio-
logical dimensions of implementing a seasonal influenza
immunization program are achieved [39], there are
operational dimensions of seasonal influenza vaccine
programs to consider. As important as availability of
a yearly seasonal influenza vaccine is the design and
implementation of a variety of strategies and activities
to achieve adequate levels of effective immunization
coverage among high-risk populations. Even in high-
income countries with established SIV programs targeting
high-risk populations and available vaccine, the rates
of vaccination are far from ideal, while elderly adults at risk
of influenza remain reluctant of vaccination [77]. Currently,
there is little agreement on the ideal vaccination strategies
and the ideal selection of target groups to receive seasonal
influenza vaccine [40,78]. For instance, there is even lack of
consensus on the benefit of seasonal influenza vaccination
in the elderly [40]. Recent Cochrane Reviews [12] have
cast doubt on the scientific evidence behind current
consensus recommendations to vaccinate the elderly
against seasonal influenza. Moreover, in some regions,
a lack of harmonization of vaccination strategies andselection of high-risk populations have contributed to in-
sufficient vaccination coverage of some target groups [42].
Differences in vaccination strategies have provided varied
results. In Japan, vaccination against influenza among
school-aged children demonstrated an important impact in
the elderly [79], while other studies have shown that
nationwide vaccination programs may be better alternatives
to decrease influenza-associated mortality in the elderly
[46]. On the other hand, non-specific preventive measures
such as hand-washing, distance, and wearing a mask during
periods of risk are useful [40] and even desirable given the
difficulty to distinguish influenza from influenza-like illness
and the concurrent circulation of diverse respiratory
viruses. These supplemental and basic measures should be
emphasized in prevention messages, especially when and
where there are no means to avoid the barriers against
influenza vaccine uptake.
The significance of qualitative research has been
increasingly recognized in health sciences disciplines;
however, efforts to integrate or synthesize qualitative
findings have been relatively limited, particularly with
the topic of influenza vaccination [23,24]. Evidence from
qualitative and quantitative studies that examine social
determinants of health, factors that shape the delivery
and implementation of interventions, and the experience of
persons involved in providing and receiving interventions
improves the scope and relevance of systematic reviews to
policy-makers and practitioners [20,80,81]. Furthermore,
situating the results of the review within the social determi-
nants of health model may provide a conceptual framework
particularly useful for global policy making [18,82].
This study has certain limitations. The study may have
source bias, since we did not search in the grey literature
or unpublished studies and used qualitative research and
filter terms instead of free text searching [24]. We did
not search specific regional databases that may be more
suitable to report research from developing countries.
As only studies written in English were included, we
may have missed studies from developing countries
published in other languages. Since more than half of
the studies were conducted in developed countries and
in urban areas, low and middle-income as well as rural
regions may be underrepresented. The inclusion of studies
relying on cross-sectional survey methods may introduce
selection bias as it is not possible to control for individuals
refusing to be interviewed. Most importantly, associations
between vaccine uptake and other variables found in
cross-sectional surveys do not involve causal relationships
[32], and such associations may be confounded by other
factors [40,78,83]. Limitations of the meta-synthesis
methodology similarly include the inability to infer
causal relationships from mixed qualitative and quantitative
data. There is little consensus on the use of quality
appraisal in qualitative meta-synthesis [20]; therefore,
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quality rating schemes. However, our search strategy
was appropriate to explore social determinants in our
population of interest.
The fact that most studies evaluated in this systematic
review came from high-income countries illustrates that
seasonal influenza vaccine is not routinely offered in low
and middle-income countries. Particularly, we can assume
that non-served and underserved populations are not rou-
tinely offered seasonal influenza vaccine because this is not
a standard public health practice or a public health priority
in many low-and medium income countries, where deter-
minants such as vaccine availability as well as financial
and political barriers prevent the effective deployment
of these interventions. Finally, because influenza vaccine
effectiveness may be suboptimal, especially in older
people [12], the opportunity to prevent influenza related
complications in this population will benefit from the
development of more immunogenic vaccines that could
be used and shared at affordable costs to populations in
high-, middle-, and low income countries. Newer influenza
vaccines such as the universal influenza vaccines may
potentially change the landscape of influenza vaccine
protection by providing long term protection and
avoiding the need of yearly revaccination [5].
Conclusion
Seasonal influenza remains a public health challenge
with important economic and social tolls. While the pre-
cise epidemiology has not been completely deciphered
in middle-and low-income countries, it is likely that this
burden is shared globally. Our results also highlight that
policies, practices, and vaccination strategies against
seasonal influenza vaccination are influenced by social
determinants where vaccine is routinely available. Some
of these determinants are health-system related, provider-
related, or patient-related resulting in variable coverage
levels within countries. While vaccination efforts continue
to expand to middle-and low income countries, there is
minimal representation of underserved populations in
currently available reports. This issue demonstrates that
larger social determinants influence the availability and
vaccination practices in these areas. Incorporating a
framework that takes into account social determinants
of health into vaccine policy design and implementation
may foster immunization equity among the most
vulnerable populations against seasonal influenza and
likely other vaccine preventable diseases. Incorporating
a social determinants framework will also allow decision
makers to identify where determinants are located
(within or outside the health sector) and serve to adopt
mechanisms for intersectoral action to address those
determinants originating outside the realm of the health
sector.Appendix 1
Keywords used for search
#1 Seasonal influenza vaccine: “Influenza Vaccines”
[MeSH] OR “Influenza, Human/prevention and control”
[MeSH], “seasonal influenza vaccine” , “seasonal influenza
vaccines”, NOT pandemic, NOT epidemic.
#2 Elderly adults: (old* or pension* or retire* or aged or
elderly or senior* or geriatric*) or (“long-term care” or
“nursing care” or “palliative care” or “homes for the aged”
or “nursing homes”), or (Community dwelling, homebound,
community ).
#3 Qualitative research: (Qualitative Research[MeSH])
OR (Nursing Methodology Research[MeSH]) OR quali-
tative or ethnograph* or phenomenol* or ethnonurs* or
grounded theory* or (lived experience*) or narrative* or
(life experiences) or (cluster sample) or (action research)
or (observational method) or (content analysis) or (thematic
analysis) or (constant comparative method) (discourse
analysis) or (focus group*) or (ethnological research)
or ethnomethodolog* or (mixed methods).
#4 SDH, inequalities: “Healthcare Disparities”[Mesh]
OR “healthcare disparities” OR “health care disparities”
OR “Healthcare Disparity” OR “Health care Disparity”
OR “Health Status Disparities”[Mesh] OR “health status
disparities” or “health status disparity” OR “Social Class”
[Mesh] OR “social mobilities” OR “ social mobility” OR
“Poverty Areas”[Mesh] OR “poverty areas” OR “poverty
area” OR “slums” OR “slum” OR “ghetto” OR “ghettos”
OR “Educational Status”[Mesh] OR “educational status”
OR “Educational Achievement*” OR “Illiteracy” OR
“Literacy” OR “Cross-Cultural Comparison”[Mesh] OR
“Cross-Cultural Comparison” OR “Cross-Cultural
Comparisons” OR “Transcultural Studies” OR “Trans-
cultural Study” OR “Prejudice” [Mesh] OR “Prejudice” OR
“Prejudices” OR “Racism” OR “Social Discrimination” OR
“Sexism” OR “Gender Bias” OR “Sex Bias” OR “Sex
Discrimination” OR “Ageism” OR “Segregation” OR
“caste” OR “castes” OR “ resource poor” OR “inequities”
OR “inequality” OR “inequalities” OR “Socioeconomic
Factors”[Mesh] OR “Socioeconomic Status” [Mesh] OR
“social class” OR “social classes” OR “socioeconomic status”
OR “Social Environment”[Mesh] OR “social environment”
OR “social environments” OR “Social Conditions”[Mesh]
OR “social conditions” OR “social condition” OR “low
income populations” OR “low income population” OR
“Vulnerable populations” [Mesh] OR “vulnerable popula-
tions” OR “vulnerable population” OR “Sensitive Popula-
tions “ OR “Sensitive Population” OR “Disadvantaged” [TI]
OR “Social Determinants”[TIAB] OR “socio-economic
status” OR “Policy” OR “Government”, OR “social health
determinants”, OR “low income”, OR “minority”, poverty,
#5 Barriers:
Barriers, barrier, access barriers, travel time, geographic
location, availability of services, geographic distribution of
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